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Background and Objectives: Evaluation of long-term
results using a thermal balloon endometrial ablation
technique to treat menorrhagia and hypermenorrhea,
considered dysfunctional uterine bleedings.
Methods: A single-arm, prospective study with long-
term follow-up of 48 months at the department of obstet-
rics and gynecology, University of Kiel, Germany.
Following hysteroscopic evaluation of the uterine cavity
and fractionated curettage, the Cavaterm endometrial
thermal ablation technique was performed on 70 patients
over the age of 40 with menorrhagia and hypermenor-
rhea in whom medical treatment had previously failed.
The study included a group of 10 patients with adeno-
myosis and uterine fibroids.
Results: In 65 patients, a complete 48-month follow-up
evaluation was possible: 58% of patients reported amen-
orrhea and 33% hypomenorrhea. Nine percent of
patients remained eumenorrheic. Fifty percent of the
small group with failed indications for the procedure had
to undergo a hysterectomy.
Conclusions: The Cavaterm thermal coagulation system
in the earlier mode of application (15 minutes at a tem-
perature of 70°C and a pressure of 200 mm Hg) is a safe
and highly effective method of endometrial ablation
resulting in a minimal amount of posttreatment menstru-
al bleeding.
Key Words: Thermal balloon, Endometrial ablation,
Cavaterm™ system, Long-term results.
INTRODUCTION
By 1937 Badenheuer1 had already published a paper on
electrocoagulation of the endometrium to treat dysfunc-
tional uterine bleeding. After Lindemann2 introduced
hysteroscopy, using the resectoscope for hysteroscopic
endometrial ablation, this technique became widely
accepted. In 1981 Goldrath3 et al applied laser energy for
endometrial ablation. In rollerball electrocoagulation,
electrosurgical resection of the endometrium is essential-
ly performed.4-6
Because of the thickness of the endometrium, pretreat-
ment with GnRH analogues has been widely discussed
and applied. When fluid distension is used for hys-
teroscopy, the view is often obscured by debris and
bleeding. There can be serious complications of fluid
overload and electrolyte imbalance. To avoid this prob-
lem, Goldrath3 performed CO2 hysteroscopy with YAG
laser ablation. This technique appeared to be extremely
skill intensive.
Our group has had broad experience with the Cavaterm
technique of thermal coagulation of the endometrium, a
balloon technique for endometrial ablation that is easy to
perform and very effective.
METHODS
We designed a prospective, single-arm study to evaluate
the efficacy of the Cavaterm™ system. Women beyond
the age of 40 requiring endometrial ablation for menor-
rhagia and hypermenorrhea were included in the study,
with the requirement that hormonal treatment for their
bleeding had previously failed.
Patients were divided into 2 groups. Group A was a small
group of 10 patients with adenomyosis and an enlarged
fibroid uterus in addition to menorrhagia and hyperme-
norrhea. These patients were informed preoperatively
that the effectiveness of the procedure could not be
guaranteed but that a successful endometrial ablation
would rule out the necessity for performing a hysterec-
tomy. If the endometrial ablation failed, a hysterectomy
would have to be performed. Group B consisted of 60
patients with normal pap smears, no distortion of the
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uterine cavity, no polyps or myomas in the uterine cavi-
ty, no pelvic inflammatory disease, and no long-term
steroid use. Patients were contacted at 3, 9, and 48
months postablation to assess their bleeding behavior
and well-being.
All procedures were carried out with patients under gen-
eral anesthesia. No specific postoperative medication was
applied.
Cavaterm Balloon Application
The Cavaterm™ plus system consists of a balloon catheter
that utilizes a combination of heat, pressure, and circula-
tion to destroy the endometrium and the underlying
myometrium to a depth of 6-8 mm. This simple, painless
treatment takes 8-15 minutes. After hysteroscopic exami-
nation of the uterine cavity, dilation and curettage is per-
formed, the cavity length measured, and the catheter
adjusted to the cervical length. No coagulation takes
place within the cervix. After the balloon has been insert-
ed, it is inflated to 200 mm Hg; and heat circulation (reg-
ulated by the Cavaterm central unit) is initiated for 10
minutes. The balloon is then deflated and removed from
the uterus, and the treatment is terminated (Figures 1-3).
RESULTS
Data from 70 patients treated between 1996 and 2000 at
our department were evaluated 3 and 48 months after the
procedure. The bleeding pattern of the 70 patients after 3
months and 9 months and of the remaining 65 patients
after 4 years is shown in Figure 4. The treatment out-
come according to age shows a remaining cyclic function
in patients older than 50 years mainly due to hormonal
replacement therapy.
The 48-month evaluation of bleeding patterns in the 65
patients is shown in Table 1. Five patients in group A
underwent a hysterectomy because of continuous bleed-
ing. For 50% of patients in group A who underwent this
treatment to avoid a hysterectomy, the Cavaterm
endometrial ablation technique was effective. After 48
months, the bleeding status of the 60 patients (including
the hormonal replacement therapy patients) with a cor-
rect indication for endometrial ablation by Cavaterm was
amenorrhea 58%, hypomenorrhea (a substantial decrease
in blood flow) 33%. Nine percent of patients were clas-
Figure 1. Cavaterm™ plus system, detailing balloon measure-
ment and optimal cavity fit.
Table 1.
Outcome 48 Months After Thermal Balloon Coagulation of Endometrium in 2 Groups of Patients
Group A (n = 10) Group B (n = 60)
n% n %
Hysterectomies following failures (n = 5) 55 0 - -
Bleeding patterns at 48 months (n = 65)
Amenorrhea - - 35 58
Hypomenorrhea 5 50 20 33
Eumenorrhea - - 5 9sified as eumenorrheic and showed a regularity of men-
struation compared with the previous menorrhagia and
hypermenorrhea. The 2-year review demonstrates the
durability of the bleeding reduction with the Cavaterm
system.
The probability of amenorrhea was found to increase
with age (Figure 5).
JSLS(2002)6:305-309 307
Complications
No intraoperative or postoperative complications were
encountered with the Cavaterm system, and none were
reported within the observation period of 4 years. All
patients were treated on an inpatient basis and dis-
charged on the following day or the day after according
to the regulations of our hospital. No postoperative
inflammation occurred, and no reports of specific pain
were made. On the contrary, we found an overall high
Figure 2. Cavaterm™ central unit for the regulation of heat and
pressure.
Figure 3. Cavaterm™ balloon compliance.
Figure 4. Bleeding pattern in 70 patients over 48 months.
Figure 5. Bleeding pattern 48 months after Cavaterm endome-
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satisfaction rate and good acceptance in our collective
patients.
DISCUSSION
On reviewing the literature on traditional hysteroscopic
techniques and the vast number of endometrial ablation
reports, especially endometrial resection for the treatment
of menorrhagia,7 hysterectomy after endometrial ablation
is only indicated in specific cases.8 Follow-up reports
over a period of more than 5 years exist.
Thermoregulated endometrial ablation reports over a 4-
year period, as described in this paper, compare favor-
ably with hysteroscopically-guided laser or electrosurgical
ablation. Pretreatment with GnRH agonists, if a curettage
is performed, as in our cases, remains open to discus-
sion.9,10 Long-term results do not appear to be dependent
upon preoperative GnRH agonist treatment.
A recent study by Gallinat and Cosgriff11 shows favorable
outcomes with the Vesta™ system, which allows for pre-
cise regional delivery of radiofrequency energy, assuring
a thorough and safe treatment of the entire uterine cavi-
ty. Our results with the Cavaterm balloon compare favor-
ably with those of Gallinat’s study. The Cavaterm balloon
seems to ideally adjust itself to the uterine cavity; and the
applied pressure, heat, and vibration deliver a smooth
heat attack to the endometrium. Our postoperative hys-
teroscopic controls always showed a smooth, brownish
coagulated endometrium, and the ostia remained
untouched in almost all cases.
Numerous global ablation systems exist, including
cryoablation, hydro-thermal ablation,12 interstitial laser
heating,13 microwave,14 an intrauterine hormone delivery
device,15 and the Vesta electroballoon application.11 The
water balloon systems that use either glucose or fructose
as a distension medium16-18 seem to be sophisticated in
their application. Precise energy delivery can be con-
trolled, and computer software provides a safe and effi-
cient treatment for dysfunctional uterine bleeding includ-
ing hypomenorrhea and amenorrhea. Patients must be
carefully selected for the treatment, which promises to be
effective if patients meet the screening requirements.
Favorable results and convincing evidence speak for the
application of the Cavaterm balloon catheter system.
CONCLUSIONS
The evaluation of long-term results with the thermal bal-
loon endometrial ablation technique of Cavaterm for the
treatment of menorrhagia and hypermenorrhea for dys-
functional uterine bleeding proved to be an effective
method resulting in a minimal amount of posttreatment
menstrual bleeding. We found that the Cavaterm thermal
coagulation system in the earlier mode of application (15
minutes at a temperature of 70°C and a pressure of 200
mm Hg) was highly successful. In 65 of the selected
patients, a complete 48-month follow-up was possible. In
this group, 58% reported amenorrhea, 30% hypomenor-
rhea, and 9% of patients remained amenorrheic. These
results speak for the effectiveness of the Cavaterm sys-
tem. In view of the new Cavaterm plus system with a
shorter and better-regulated coagulation, even better
results are expected.
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